Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michele Cavo
Pomalidomide Plus Low-Dose Dexamethasone Versus High-Dose Dexamethasone Alone for Patients With Relapsed and Refractory Multiple Myeloma (MM-003): A Randomised, Open-Label, Phase 3 Trial
The Lancet Oncology
Oncology
Serum Free Immunoglobulin Light Chain Evaluation as a Marker of Impact From Intraclonal Heterogeneity on Myeloma Outcome
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Minimal Residual Disease by Flow Cytometry and Allelic-Specific Oligonucleotide Real-Time Quantitative Polymerase Chain Reaction in Patients With Myeloma Receiving Lenalidomide Maintenance: A Pooled Analysis
Cancer
Cancer Research
Oncology
Recommendations for Acquisition, Interpretation and Reporting of Whole Body Low Dose CT in Patients With Multiple Myeloma and Other Plasma Cell Disorders: A Report of the IMWG Bone Working Group
Blood Cancer Journal
Oncology
Hematology
Once- Versus Twice-Weekly Carfilzomib in Relapsed and Refractory Multiple Myeloma by Select Patient Characteristics: Phase 3 A.R.R.O.W. Study Subgroup Analysis
Blood Cancer Journal
Oncology
Hematology
Daratumumab-Based Regimens Are Highly Effective and Well Tolerated in Relapsed or Refractory Multiple Myeloma Regardless of Patient Age: Subgroup Analysis of the Phase 3 CASTOR and POLLUX Studies
Haematologica
Hematology
European Perspective on Multiple Myeloma Treatment Strategies: Update Following Recent Congresses
Oncologist
Cancer Research
Medicine
Oncology
The Berlin-Frankfurt-Münster Protocol for the Upfront Treatment of Aggressive Lymphomas: The Bologna Experience
American Journal of Hematology
Hematology
Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation
Frontiers in Immunology
Allergy
Immunology
Safety and Efficacy of Ruxolitinib in Myelofibrosis Patients Without Splenomegaly
British Journal of Haematology
Hematology
1
2
›
